Search tips
Search criteria 


Logo of jroyalcgpracBJGP at RCGPBJGP at PubMed CentralJ R Coll Gen Pract at PubMed CentralRCGP homepage
J R Coll Gen Pract. 1989 July; 39(324): 292–296.
PMCID: PMC1711909

Treatment of hay fever.


The range of treatments for hay fever available to the general practitioner has changed considerably in recent years. New antihistamines have addressed the problem of sedation and moved towards one daily dose; nasally applied corticosteroids avoid the need for systemic steroid therapy and its potential adverse effect; and regulatory decisions have set a trend away from immunotherapy in general practice. However, knowledge about the mechanism of action of immunotherapy is increasing and new developments with improved safety profiles include allergen polymers, allergoids, oral immunotherapy and nasal immunotherapy. Choice of treatment depends, as always, on the individual circumstances of the patient and his or her disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wood SF. Hay fever. 2. Clinical features, diagnosis, investigation and treatment. Fam Pract. 1986 Jun;3(2):120–125. [PubMed]
  • Wheatley D. Ketotifen in hay fever and allergic rhinitis. Practitioner. 1984 Jul;228(1393):685–686. [PubMed]
  • Chung KF, Barnes PJ. Respiratory and allergic disease. I. Br Med J (Clin Res Ed) 1988 Jan 2;296(6614):29–33. [PMC free article] [PubMed]
  • Holgate ST, Howarth PH. Treating hay fever. Br Med J (Clin Res Ed) 1985 Jul 13;291(6488):92–92. [PMC free article] [PubMed]
  • Howarth PH, Holgate ST. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax. 1984 Sep;39(9):668–672. [PMC free article] [PubMed]
  • Wood SF. Astemizole and terfenadine compared in hay fever. Practitioner. 1986 Jan;230(1411):41–44. [PubMed]
  • Kemp JP, Buckley CE, Gershwin ME, Buchman E, Cascio FL, Chretien JH, Foster TS, Gordon WE, Jakle C, Klemawesch SJ, et al. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy. 1985 Jun;54(6):502–509. [PubMed]
  • Girard JP, Sommacal-Schopf D, Bigliardi P, Henauer SA. Double-blind comparison of astemizole, terfenadine and placebo in hay fever with special regard to onset of action. J Int Med Res. 1985;13(2):102–108. [PubMed]
  • Rökenes HK, Andersson B, Rundcrantz H. Effect of terfenadine and placebo on symptoms after nasal allergen provocation. Clin Allergy. 1988 Jan;18(1):63–69. [PubMed]
  • Shuster S. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax. 1986 Aug;41(8):654–654. [PMC free article] [PubMed]
  • Skassa-Brociek W, Bousquet J, Montes F, Verdier M, Schwab D, Lherminier M, Michel FB. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1988 Apr;81(4):725–730. [PubMed]
  • Pécoud A, Zuber P, Kolly M. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test. Int Arch Allergy Appl Immunol. 1987;82(3-4):541–543. [PubMed]
  • Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11;316(24):1506–1510. [PubMed]
  • Boyd G, Langan CE, Langan JJ. Beclomethasone dipropionate in seasonal allergic rhinitis. A comparison of two preparations. Practitioner. 1985 Sep;229(1407):823–825. [PubMed]
  • Orgel HA, Meltzer EO, Kemp JP, Welch MJ. Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol. J Allergy Clin Immunol. 1986 Jun;77(6):858–864. [PubMed]
  • Pipkorn U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever. Effect of topical glucocorticoid treatment. Int Arch Allergy Appl Immunol. 1987;84(2):123–128. [PubMed]
  • Vanzieleghem MA, Juniper EF. A comparison of budesonide and beclomethasone dipropionate nasal aerosols in ragweed-induced rhinitis. J Allergy Clin Immunol. 1987 Jun;79(6):887–892. [PubMed]
  • Welsh PW, Stricker WE, Chu CP, Naessens JM, Reese ME, Reed CE, Marcoux JP. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc. 1987 Feb;62(2):125–134. [PubMed]
  • Druce HM, Kaliner MA. Allergic rhinitis. JAMA. 1988 Jan 8;259(2):260–263. [PubMed]
  • Santoni P, Perdona B, Read BH. Seasonal allergic rhinitis. Practitioner. 1984 May;228(1391):460–462. [PubMed]
  • Ruhno J, Denburg J, Dolovich J. Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis. J Allergy Clin Immunol. 1988 Mar;81(3):570–574. [PubMed]
  • Sipilä P, Sorri M, Pukander J. Double-blind comparison of nedocromil sodium (1% nasal spray) and placebo in rhinitis caused by birch pollen. Clin Otolaryngol Allied Sci. 1987 Oct;12(5):365–370. [PubMed]
  • Rands DA. Anaphylactic reaction to desensitisation for allergic rhinitis and asthma. Br Med J. 1980 Sep 27;281(6244):854–854. [PMC free article] [PubMed]
  • Möller C, Dreborg S, Einarsson R. Immunotherapy to deciduous tree pollens: specific IgE and IgG antibody patterns. Clin Allergy. 1987 Nov;17(6):551–562. [PubMed]
  • Rak S, Håkansson L, Venge P. Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapy. Int Arch Allergy Appl Immunol. 1987;82(3-4):349–350. [PubMed]
  • Grammer LC, Shaughnessy MA, Finkle SM, Shaughnessy JJ, Patterson R. Safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with multiple inhalant sensitivities. J Allergy Clin Immunol. 1986 Jan;77(1 Pt 1):53–58. [PubMed]
  • Grammer LC, Shaughnessy MA, Finkle SM, Shaughnessy JJ, Patterson R. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis. J Allergy Clin Immunol. 1986 Dec;78(6):1180–1184. [PubMed]
  • Bousquet J, Hejjaoui A, Skassa-Brociek W, Guérin B, Maasch HJ, Dhivert H, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol. 1987 Oct;80(4):591–598. [PubMed]
  • Bousquet J, Frank E, Soussana M, Hejjaoui A, Maasch HJ, Michel FB. Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy. Int Arch Allergy Appl Immunol. 1987;82(3-4):550–552. [PubMed]
  • Möller C, Dreborg S. Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results. Clin Allergy. 1986 Mar;16(2):135–143. [PubMed]
  • Juniper EF, O'Connor J, Roberts RS, Evans S, Hargreave FE, Dolovich J. Polyethylene glycol-modified ragweed extract: comparison of two treatment regimens. J Allergy Clin Immunol. 1986 Nov;78(5 Pt 1):851–856. [PubMed]
  • Taudorf E, Laursen LC, Lanner A, Björksten B, Dreborg S, Søborg M, Weeke B. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol. 1987 Aug;80(2):153–161. [PubMed]
  • Van Niekerk CH, De Wet JI. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study. Clin Allergy. 1987 Nov;17(6):507–513. [PubMed]
  • Nickelsen JA, Georgitis JW, Mueller UR, Kane J, Wypych JI, Goldstein S, Reisman RE, Arbesman CE. Local nasal immunotherapy for ragweed-allergic rhinitis. III. A second year of treatment. Clin Allergy. 1983 Nov;13(6):509–519. [PubMed]
  • Georgitis JW, Nickelsen JA, Wypych JI, Kane JH, Reisman RE. Local nasal immunotherapy: efficacy of low-dose aqueous ragweed extract. J Allergy Clin Immunol. 1985 Apr;75(4):496–500. [PubMed]
  • Georgitis JW, Nickelsen JA, Wypych JI, Barde SH, Clayton WF, Reisman RE. Local intranasal immunotherapy with high-dose polymerized ragweed extract. Int Arch Allergy Appl Immunol. 1986;81(2):170–173. [PubMed]
  • Guill MF, Buckley RH, Rocha W, Jr, Kemp JP, Segal AT, Shirley LR, Tinkelman DG, Shaath-Schwen Z, Dietrich KK, Wille LJ, et al. Multicenter, double-blind, placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in children. J Allergy Clin Immunol. 1986 Jul;78(1 Pt 1):4–9. [PubMed]
  • Kjellman NI, Andersson B. Terfenadine reduces skin and conjunctival reactivity in grass pollen allergic children. Clin Allergy. 1986 Sep;16(5):441–449. [PubMed]
  • Mansfield JR. The clinical diagnosis and treatment of rhinitis. Practitioner. 1983 Aug;227(1382):1305–1311. [PubMed]
  • Reilly DT, Taylor MA, McSharry C, Aitchison T. Is homoeopathy a placebo response? Controlled trial of homoeopathic potency, with pollen in hayfever as model. Lancet. 1986 Oct 18;2(8512):881–886. [PubMed]
  • Naclerio RM, Bartenfelder D, Proud D, Togias AG, Meyers DA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov;78(5 Pt 1):874–876. [PubMed]
  • Linder A. Symptom scores as measures of the severity of rhinitis. Clin Allergy. 1988 Jan;18(1):29–37. [PubMed]
  • D'Souza MF, Tooley M, Charlton JR. Hay fever treatments--which should be tried first? J R Coll Gen Pract. 1987 Jul;37(300):296–300. [PMC free article] [PubMed]
  • Leff S. A survey of the prevalence and treatment of asthma and hayfever in a small town in East Sussex. Public Health. 1986 Jul;100(4):205–207. [PubMed]
  • Wood SF. Oral antihistamine or nasal steroid in hay fever: a double-blind double-dummy comparative study of once daily oral astemizole vs twice daily nasal beclomethasone dipropionate. Clin Allergy. 1986 May;16(3):195–201. [PubMed]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners